or
forgot password
  • cancer clinical trials in cincinnati, OH

  • Phase 2 Study of SAR302503 in Patients With Myelofibrosis
    Investigational Site Number 840007
    Cincinnati, Ohio 45267-0542
    Hematopoietic Neoplasm
    Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
    Investigational Site Number 840002
    Cincinnati, Ohio 45267-0542
    Hematopoietic Neoplasm
    A Study of LY2510924 in Patients With Extensive-Stage Small Cell Lung Carcinoma
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Cincinnati, Ohio 45267
    Extensive Stage Small Cell Lung Carcinoma
    Letrozole in Treating Postmenopausal Women With Ductal Carcinoma in Situ
    Bethesda North Hospital
    Cincinnati, Ohio 45242
    Breast Cancer
    A Dose Escalation Study of Iniparib as a Single Agent and in Combination in Solid Tumors
    Investigational Site Number 840001
    Cincinnati, Ohio 45267-0542
    Neoplasm Malignant
    Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia
    Cincinnati Children's Hospital Medical Center

    Trial Locations
    Cincinnati Children's Hospital Medical Center
    Local Institution
    Leukemia, Pediatric
    A Study of Intra-Ophthalmic Artery Topotecan Infusion for the Treatment of Retinoblastoma
    Cincinnati Children's Hospital Medical Center
    Cincinnati, Ohio 45229-3039
    Retinoblastoma
    Alisertib in Treating Patients With Relapsed or Refractory Peripheral T-Cell Non-Hodgkin Lymphoma
    University of Cincinnati
    Cincinnati, Ohio 45267-0502
    Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, Hepatosplenic T-cell Lymphoma, Peripheral T-cell Lymphoma, Recurrent Adult Non-Hodgkin Lymphoma, Recurrent Adult T-cell Leukemia/Lymphoma
    Paclitaxel With or Without Pazopanib Hydrochloride in Treating Patients With Persistent or Recurrent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity Cancer
    University of Cincinnati
    Cincinnati, Ohio 45267-0502
    Recurrent Fallopian Tube Cancer, Recurrent Ovarian Epithelial Cancer, Recurrent Primary Peritoneal Cavity Cancer
    Clinical Study With Blinatumomab in Pediatric and Adolescent Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia
    Cincinnati Children's Hospital Medical Center
    Cincinnati, Ohio 45229-3039
    Acute Lymphoblastic Leukemia
    Efficacy and Safety of GS-6624 With FOLFIRI as Second Line Treatment in Colorectal Adenocarcinoma
    Oncology Hematology Care, Inc.
    Cincinnati, Ohio 45219
    Colorectal Cancer
    Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
    University of Cincinnati Cancer Institute
    Cincinnati, Ohio 45267
    Glioblastoma, Small Cell Glioblastoma, Giant Cell Glioblastoma, Gliosarcoma, Glioblastoma With Oligodendroglial Component
    EP-100 Plus Paclitaxel Versus Paclitaxel Alone in Patients With Ovarian Cancer
    Investigational Site Number 840004
    Cincinnati, Ohio 45267-0542
    Ovarian Cancer Recurrent
    The BEACON Study (Breast Cancer Outcomes With NKTR-102)
    University of Cincinnati
    Cincinnati, Ohio 45267-0502
    Locally Recurrent Breast Cancer, Metastatic Breast Cancer
    Phase 3 Papulopustular Rosacea Study
    Dermatology Research Center of Cincinnati
    Cincinnati, Ohio 45220
    Papulopustular Rosacea (PPR)
    AMR-001 Versus Placebo Post ST Segment Elevation Myocardial Infarction
    University of Cincinnati

    Trial Locations
    University of Cincinnati
    The Carl and Edyth Lindner Center for Research and Education at the Christ Hospital
    ST Segment Elevation Myocardial Infarction
    Morphotek Investigation in Colorectal Cancer: Research of MORAb-004 (MICRO)
    TriHealth Oncology Institute/Oncology Partners Network
    Cincinnati, Ohio 45247
    Metastatic Colorectal Cancer, Colorectal Cancer
    Safety Study of BEZ235 With Everolimus in Subjects With Advanced Solid Tumors
    University of Cincinnati
    Cincinnati, Ohio 45267-0502
    Cancer
    Phase II Axitinib (AG-013736) in Elderly Glioblastoma Multiforme (GBM) Patients
    University of Cincinnati
    Cincinnati, Ohio 45267-0502
    Glioblastoma Multiforme
    Evaluation of the Use of Trental and Vitamin E For Prophylaxis of Radiation Necrosis
    University of Cincinnati
    Cincinnati, Ohio 45267-0502
    Brain Metastasis
    Study to Evaluate Pharmacokinetics, Food Effect, Safety and Efficacy of Oral Azacitidine
    University of Cincinnati Cancer Institute UC Health Barrett Cancer Center
    Cincinnati, Ohio 45267
    Myelodysplastic Syndromes, Leukemia, Myelomonocytic, Chronic, Leukemia, Myeloid, Acute
    Topical Rapamycin to Erase Angiofibromas in TSC
    Cincinnati Children's Hospital Medical Center
    Cincinnati, Ohio 45229-3039
    Angiofibromas, Tuberous Sclerosis
    Trial of Eribulin/Cyclophosphamide or Docetaxel/Cyclophosphamide as Neoadjuvant Therapy in Locally Advanced HER2-Negative Breast Cancer
    Oncology Hematology Care, Inc
    Cincinnati, Ohio 45242
    Locally Advanced HER2-Negative Breast Cancer
    Trebananib in Treating Younger Patients With Relapsed or Refractory Solid Tumors, Including Central Nervous System Tumors
    Cincinnati Children's Hospital Medical Center
    Cincinnati, Ohio 45229-3039
    Recurrent Childhood Anaplastic Astrocytoma, Recurrent Childhood Anaplastic Oligoastrocytoma, Recurrent Childhood Anaplastic Oligodendroglioma, Recurrent Childhood Cerebellar Astrocytoma, Recurrent Childhood Cerebral Astrocytoma, Recurrent Childhood Diffuse Astrocytoma, Recurrent Childhood Fibrillary Astrocytoma, Recurrent Childhood Gemistocytic Astrocytoma, Recurrent Childhood Giant Cell Glioblastoma, Recurrent Childhood Glioblastoma, Recurrent Childhood Gliomatosis Cerebri, Recurrent Childhood Gliosarcoma, Recurrent Childhood Oligoastrocytoma, Recurrent Childhood Oligodendroglioma, Recurrent Childhood Pilocytic Astrocytoma, Recurrent Childhood Pineoblastoma, Recurrent Childhood Pleomorphic Xanthoastrocytoma, Recurrent Childhood Protoplasmic Astrocytoma, Recurrent Childhood Subependymal Giant Cell Astrocytoma, Recurrent Childhood Visual Pathway and Hypothalamic Glioma, Recurrent Childhood Visual Pathway Glioma, Unspecified Childhood Solid Tumor, Protocol Specific
    Targeted Intervention for Bipolar Smokers
    The University of Cincinnati
    Cincinnati, Ohio 452219
    Nicotine Dependence, Bipolar Disorder
    Low-Dose or High-Dose Lenalidomide in Treating Younger Patients With Recurrent, Refractory, or Progressive Pilocytic Astrocytoma or Optic Pathway Glioma
    Cincinnati Children's Hospital Medical Center
    Cincinnati, Ohio 45229-3039
    Neurofibromatosis Type 1, Recurrent Childhood Pilocytic Astrocytoma, Recurrent Childhood Visual Pathway Glioma
    Sodium Management in Acute Neurological Injury
    UC Health -University Hospital
    Cincinnati, Ohio 45219
    The Focus of the Study is to Understand the Current Practice of Sodium Management in Patients With Acute Neurological Injury.
    A Study in Recurrent Glioblastoma (GB)
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Cincinnati, Ohio 45267
    Glioblastoma
    Phase 3 Trial of Autologous Dendritic Cell Immunotherapy (AGS-003) Plus Standard Treatment of Advanced Renal Cell Carcinoma (RCC)
    TriState Urologic Services PSC Inc. The Urology Group
    Cincinnati, Ohio 45212
    Advanced Renal Cell Carcinoma, Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma
    Neuroblastoma Biology Study
    Cincinnati Children's Hospital Medical Center
    Cincinnati, Ohio 45229-3039
    Neuroblastoma
    A Study of LY2784544 in Participants With Myeloproliferative Neoplasms
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Cincinnati, Ohio 45267
    Neoplasms, Hematologic
    Study of MLN8237 in Combination With Irinotecan and Temozolomide
    Cincinnati Children's Hospital Medical Center
    Cincinnati, Ohio 45229-3039
    Neuroblastoma
    Cardiovascular Outcomes Study of Naltrexone SR/Bupropion SR in Overweight and Obese Subjects With Cardiovascular Risk Factors (The Light Study)
    Sterling Research Group

    Trial Locations
    Sterling Research Group
    The Lindner Center for Research & Education
    Obesity, Overweight
    A Study of Necitumumab Monotherapy and the QT/QTc Interval in Patient With Advanced Solid Tumors
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Cincinnati, Ohio 45267
    Solid Tumors
    Developing the Family Map: Looking at Communal Coping
    Cincinnati Children's Hospital Medical Center
    Cincinnati, Ohio 45229-3039
    Diabetes, Cancer, Cardiovascular Disease
    A Study to Assess the Pharmacokinetics of Ramucirumab in Combination With FOLFIRI
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Cincinnati, Ohio 45267
    Solid Tumors
    Immunosuppression Withdrawal for Stable Pediatric Liver Transplant Recipients
    Cincinnati Children's Hospital
    Cincinnati, Ohio 45229
    Transplantation, Liver
    Study of BMS-936558 Compared to Docetaxel in Previously Treated Advanced or Metastatic Squamous Cell Non-small Cell Lung Cancer (NSCLC)
    Oncology Hematology Care
    Cincinnati, Ohio 45242
    Squamous Cell Non-small Cell Lung Cancer
    Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003 AM5)
    Call for Information (Investigational Site 0231)
    Cincinnati, Ohio 45227
    Genital Warts, Anal Cancer, Anal Intraepithelial Neoplasia
    Safety Study of Unlicensed, Investigational Cord Blood Units Manufactured by the NCBP for Unrelated Transplantation
    Cincinnati Children's Hospital Medical Center
    Cincinnati, Ohio 45229-3039
    Infusion Reactions
    Pilot Study Of Sirolimus Plus Multiagent Chemotherapy For Relapsed/Refractory Acute Lymphoblastic Leukemia/Lymphoma
    Cincinnati Children's Hospital Medical Center
    Cincinnati, Ohio 45229-3039
    Relapsed Lymphoblastic Leukemia, Relapsed Lymphoblastic Lymphoma, Refractory Acute Lymphoblastic Leukemia, Refractory Lymphoblastic Lymphoma
    Study of Everolimus With Bevacizumab to Treat Refractory Malignant Peripheral Nerve Sheath Tumors
    Cincinnati Children's Hospital Medical Center
    Cincinnati, Ohio 45229-3039
    Malignant Peripheral Nerve Sheath Tumors, MPNST, Sarcoma
    Study of BMS-936558 Compared to Docetaxel in Previously Treated Advanced or Metastatic Non-squamous NSCLC
    Oncology Hematology Care
    Cincinnati, Ohio 45242
    Non-Squamous Cell Non-small Cell Lung Cancer
    Safety, Efficacy and Pharmacokinetic Study of PRLX 93936 in Patients With Multiple Myeloma
    University of Cincinnati
    Cincinnati, Ohio 45267-0502
    Multiple Myeloma
    A Phase III Study of Oral LDE225 Versus (vs) Temozolomide (TMZ) in Patients With Hedge-Hog (Hh)-Pathway Activated Relapsed Medulloblastoma (MB)
    Cincinnati Children's Hospital Medical Center Dept of Oncology1
    Cincinnati, Ohio 45229-3039
    Medulloblastoma
    Cabozantinib in Treating Younger Patients With Recurrent or Refractory Solid Tumors
    Cincinnati Children's Hospital Medical Center
    Cincinnati, Ohio 45229-3039
    Recurrent Melanoma, Recurrent Thyroid Cancer, Thyroid Gland Medullary Carcinoma, Unspecified Childhood Solid Tumor, Protocol Specific
    Modeling Study to Predict Progression of Anal Cancer Pre-cursor Lesions in HIV
    University of Cincinnati

    Trial Locations
    University of Cincinnati
    Cincinnati VA Medical Center
    Neoplasms, Squamous Cell, Papillomavirus Infections
    A Placebo-controlled Study of Efficacy & Safety of 2 Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) & Refractory Partial-onset Seizures
    Cincinnati Children's Hospital Medical Center SC
    Cincinnati, Ohio 45229-3039
    Tuberous Sclerosis Complex-associated Refractory Seizures
    Quercetin in Children With Fanconi Anemia; a Pilot Study
    Cincinnati Children's Hospital Medical Center
    Cincinnati, Ohio 45229-3039
    Fanconi Anemia
    Tivantinib in Treating Younger Patients With Relapsed or Refractory Solid Tumors
    Cincinnati Children's Hospital Medical Center
    Cincinnati, Ohio 45229-3039
    Unspecified Childhood Solid Tumor, Protocol Specific
    Immune Monitoring Protocol in Men With Prostate Cancer Enrolled in a Clinical Trial of Sipuleucel-T
    TriState Urologic Services PSC Inc., dba The Urology Group
    Cincinnati, Ohio 45212
    Prostate Cancer
    Exploring a Cessation Intervention for Smokers
    Cincinnati Children's Hospital Medical Center
    Cincinnati, Ohio 45229-3039
    Asthma
    Belatacept Early Steroid Withdrawal Trial
    University of Cincinnati
    Cincinnati, Ohio 45267-0502
    Renal Transplantation